These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 6207166)

  • 21. Surface expression of O-specific lipopolysaccharide in Escherichia coli requires the function of the TolA protein.
    Gaspar JA; Thomas JA; Marolda CL; Valvano MA
    Mol Microbiol; 2000 Oct; 38(2):262-75. PubMed ID: 11069653
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of the growth environment on cell-envelope components of Escherichia coli in relation to sensitivity to human serum.
    Taylor PW; Messner P; Parton R
    J Med Microbiol; 1981 Feb; 14(1):9-19. PubMed ID: 7007647
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of capsule and O antigen in resistance of Klebsiella pneumoniae to serum bactericidal activity.
    Tomás JM; Benedí VJ; Ciurana B; Jofre J
    Infect Immun; 1986 Oct; 54(1):85-9. PubMed ID: 3531020
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relative opsonic and protective activities of antibodies against K1, O and lipid A antigens of Escherichia coli.
    Welch WD; Martin WJ; Stevens P; Young LS
    Scand J Infect Dis; 1979; 11(4):291-301. PubMed ID: 93778
    [TBL] [Abstract][Full Text] [Related]  

  • 25. O-antigenic chains of lipopolysaccharide prevent binding of antibody molecules to an outer membrane pore protein in Enterobacteriaceae.
    van der Ley P; Kuipers O; Tommassen J; Lugtenberg B
    Microb Pathog; 1986 Feb; 1(1):43-9. PubMed ID: 2469929
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Studies on serum resistance in Escherichia coli.
    Kubens BS; Opferkuch W
    Zentralbl Bakteriol Mikrobiol Hyg A; 1988 Nov; 270(1-2):52-65. PubMed ID: 3146846
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunoprotective murine monoclonal antibodies specific for the outer-core polysaccharide and for the O-antigen of Escherichia coli 0111:B4 lipopolysaccharide (LPS).
    Coughlin RT; Bogard WC
    J Immunol; 1987 Jul; 139(2):557-61. PubMed ID: 3298431
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of lipopolysaccharide biosynthesis mutations on K1 polysaccharide association with the Escherichia coli cell surface.
    Jiménez N; Senchenkova SN; Knirel YA; Pieretti G; Corsaro MM; Aquilini E; Regué M; Merino S; Tomás JM
    J Bacteriol; 2012 Jul; 194(13):3356-67. PubMed ID: 22522903
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of outer membrane components of Escherichia coli ML308 225 and of a serum-resistant mutant.
    Tee GL; Scott GK
    Infect Immun; 1980 May; 28(2):387-92. PubMed ID: 6995308
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stable insertion of C5b-9 complement complexes into the outer membrane of serum treated, susceptible Escherichia coli cells as a prerequisite for killing.
    Kroll HP; Voigt WH; Taylor PW
    Zentralbl Bakteriol Mikrobiol Hyg A; 1984 Dec; 258(2-3):316-26. PubMed ID: 6397947
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of K-1 capsule, smooth lipopolysaccharides, traT gene, and Colicin V production with complement resistance and virulence of avian Escherichia coli.
    Wooley RE; Nolan LK; Brown J; Gibbs PS; Giddings CW; Turner KS
    Avian Dis; 1993; 37(4):1092-6. PubMed ID: 8141739
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Release of outer membrane fragments from wild-type Escherichia coli and from several E. coli lipopolysaccharide mutants by EDTA and heat shock treatments.
    Marvin HJ; ter Beest MB; Witholt B
    J Bacteriol; 1989 Oct; 171(10):5262-7. PubMed ID: 2507517
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of a cloned lipopolysaccharide antigen from Neisseria gonorrhoeae on the surface of Escherichia coli K-12.
    Palermo DA; Evans TM; Clark VL
    Infect Immun; 1987 Nov; 55(11):2844-9. PubMed ID: 3117695
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Septicemia-inducing Escherichia coli O115:K"V165"F165(1) resists killing by porcine polymorphonuclear leukocytes in vitro: role of F165(1) fimbriae and K"V165" O-antigen capsule.
    Ngeleka M; Martineau-Doizé B; Fairbrother JM
    Infect Immun; 1994 Feb; 62(2):398-404. PubMed ID: 7507891
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Loss of resistance to ingestion and phagocytic killing by O(-) and K(-) mutants of a uropathogenic Escherichia coli O75:K5 strain.
    Burns SM; Hull SI
    Infect Immun; 1999 Aug; 67(8):3757-62. PubMed ID: 10417134
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Studies of the mechanism of bacterial resistance to complement-mediated killing. V. IgG and F(ab')2 mediate killing of E. coli 0111B4 by the alternative complement pathway without increasing C5b-9 deposition.
    Joiner KA; Goldman RC; Hammer CH; Leive L; Frank MM
    J Immunol; 1983 Nov; 131(5):2563-9. PubMed ID: 6355296
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antigenic and immunogenic differences in lipopolysaccharides of Escherichia coli J5 vaccine strains of different origins.
    Appelmelk BJ; Maaskant JJ; Verweij-van Vught AM; van der Meer NM; Thijs BG; MacLaren DM
    J Gen Microbiol; 1993 Nov; 139(11):2641-7. PubMed ID: 7506295
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pseudomonas aeruginosa isolates from patients with cystic fibrosis: a class of serum-sensitive, nontypable strains deficient in lipopolysaccharide O side chains.
    Hancock RE; Mutharia LM; Chan L; Darveau RP; Speert DP; Pier GB
    Infect Immun; 1983 Oct; 42(1):170-7. PubMed ID: 6413410
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic and biochemical analysis of Shigella dysenteriae 1 O antigen polysaccharide biosynthesis in Escherichia coli K-12: 9 kb plasmid of S. dysenteriae 1 determines addition of a galactose residue to the lipopolysaccharide core.
    Sturm S; Jann B; Jann K; Fortnagel P; Timmis KN
    Microb Pathog; 1986 Jun; 1(3):299-306. PubMed ID: 2469932
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of a polysaccharide capsular antigen of septicemic Escherichia coli O115:K "V165" :F165 and evaluation of its role in pathogenicity.
    Ngeleka M; Harel J; Jacques M; Fairbrother JM
    Infect Immun; 1992 Dec; 60(12):5048-56. PubMed ID: 1452337
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.